| NCT Number | NCT07422675 |
| Lead Sponsor | Serina Therapeutics |
| Conditions | PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease |
| Enrollment | 40 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2027-01-31 (estimated) |
| Study Completion | 2027-01-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-05 |